Front Matter
Article Sidebar
Main Article Content
Downloads
Metrics
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright of individual chapters belongs to the respective authors. The authors grant unrestricted publishing and distribution rights to the publisher. The electronic versions of the chapters are published under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). Users are allowed to share and adapt the chapters for any non-commercial purposes as long as the authors and the publisher are explicitly identified and properly acknowledged as the original source. The books in their entirety are subject to copyright by the publisher. The reproduction, modification, republication and display of the books in their entirety, in any form, by anyone, for commercial purposes are strictly prohibited without the written consent of the publisher.
Toshiyuki Araki, MD, PhD (Editor), Department of Peripheral Nervous System Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Japan
Toshiyuki Araki, MD, PhD, is Director of the Department of Peripheral Nervous System Research at the National Institute of Neuroscience of the National Center of Neurology and Psychiatry (Tokyo, Japan), visiting professor at Tokyo University of Agriculture and Technology (Tokyo, Japan), and lecturer at Waseda University (Tokyo, Japan) and Osaka University (Osaka Japan). He graduated from Osaka University, where he received MD and PhD degrees. He performed postgraduate training at the Washington University School of Medicine in St. Louis (Missouri, USA). The research interest of Dr. Araki has been focused on the neuronal/axonal degeneration mechanisms and application of the knowledge to the therapeutic development. The targets of his research range from peripheral nerve degeneration/regeneration and neuromuscular disorders to neurodegenerative disorders including amyotrophic lateral sclerosis and Alzheimer’s disease, and developmental disorders including autism-spectrum disorders. For promoting translational research, he has been collaborating with several pharmaceutical companies. He also serves as the chairman of National Center of Neurology and Psychiatry Ethics Committee for clinical research, and an ethical advisor to Brain/Minds Beyond project. He has authored more than 100 scientific publications. He also serves as an editorial member of scientific journals, and a board member/councilor of several scientific societies.